GRANTHAM, MAYO, VAN OTTERLOO & CO. LLC – Regeneron Pharmaceuticals, Inc. Transaction History
GRANTHAM, MAYO, VAN OTTERLOO & CO. LLC portfolio value:
$37.19M
portfolio value
GRANTHAM, MAYO, VAN OTTERLOO & CO. LLC quarter portfolio value change:
+16.53%
quarter
Regeneron Pharmaceuticals, Inc. 13F transactions
| Quarter | Transaction type | Change | Relative change | Absolute change | Change value | Avg. price | Shares |
|---|---|---|---|---|---|---|---|
| Q3 2022 | share | Decrease | -4.26% | -2.4K shares | 3.85M | $688.87 | 54K |
| Q2 2022 | share | Increase | +17.75% | 8.5K shares | -114K | $591.13 | 56.4K |
| Q1 2022 | share | Increase | +1.05% | 500 shares | 3.52M | $698.42 | 47.9K |
| Q4 2021 | share | Decrease | -3.85% | -1.9K shares | 99K | $642.51 | 47.4K |
| Q3 2021 | share | Increase | +1.65% | 800 shares | 2.74M | $605.18 | 49.3K |
| Q2 2021 | share | Increase | +16.59% | 6.9K shares | 7.40M | $558.54 | 48.5K |
| Q1 2021 | share | Increase | +47.75% | 13.44K shares | 6.08M | $473.14 | 41.6K |
| Q4 2020 | share | Increase | +6074.56% | 27.7K shares | 13.34M | $483.11 | 28.15K |
| Q3 2020 | share | 0.00% | 0 shares | -29K | $559.78 | 456 | |
| Q2 2020 | share | Increase | 0.00% | 456 shares | 284K | $623.65 | 456 |
| Q3 2019 | share | Decrease | -100.00% | -11.1K shares | -3.47M | $277.4 | 0 |
| Q2 2019 | share | Increase | +2120.00% | 10.6K shares | 3.26M | $313 | 11.1K |
| Q1 2019 | share | Increase | 0.00% | 500 shares | 205K | $410.62 | 500 |